Healthcare ❯ Pharmaceuticals ❯ Drug Approval Process ❯ COVID-19 Vaccines
His departure closes a brief tenure that saw him impose stricter COVID-19 vaccine guidelines under political scrutiny over a Duchenne muscular dystrophy gene therapy review.
